Inhibitors of hepatitis C virus NS3·4A protease 1. Non-Charged tetrapeptide variants (Q42980953)

12 November 2017

title

Inhibitors of hepatitis C virus NS3.4A protease 1. Non-charged tetrapeptide variants (English)

1 reference

12 November 2017

Inhibitors of hepatitis C virus NS3·4A protease 1. Non-Charged tetrapeptide variants (English)

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2003.08.050

27 March 2024

1 reference

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2003.08.050

27 March 2024

pharmaceutical science

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2003.08.050

27 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2003.08.050

27 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2003.08.050

27 March 2024

author name string

Yu-Ping Luong

12

1 reference

12 November 2017

Janos Pitlik

14

1 reference

12 November 2017

Yunyi Wei

20

1 reference

12 November 2017

Robert B. Perni

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14592508

27 March 2024

Shawn D. Britt

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14592508

27 March 2024

John C. Court

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14592508

27 March 2024

Lawrence F. Courtney

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14592508

27 March 2024

David D. Deininger

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14592508

27 March 2024

Luc J. Farmer

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14592508

27 March 2024

Cynthia A. Gates

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14592508

27 March 2024

Scott L. Harbeson

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14592508

27 March 2024

Joseph L. Kim

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14592508

27 March 2024

James A. Landro

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14592508

27 March 2024

Rhonda B. Levin

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14592508

27 March 2024

Ethan T. O'Malley

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14592508

27 March 2024

B. Govinda Rao

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14592508

27 March 2024

Wayne C. Schairer

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14592508

27 March 2024

John A. Thomson

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14592508

27 March 2024

Roger D. Tung

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14592508

27 March 2024

John H. Van Drie

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14592508

27 March 2024

language of work or name

English

0 references

publication date

1 November 2003

1 reference

12 November 2017

17 November 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14592508

full work available at URL

27 March 2024

https://api.elsevier.com/content/article/PII:S0960894X03009132?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2003.08.050

https://api.elsevier.com/content/article/PII:S0960894X03009132?httpAccept=text/plain

27 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2003.08.050

Bioorganic & Medicinal Chemistry Letters

27 March 2024

published in

1 reference

12 November 2017

volume

13

1 reference

12 November 2017

issue

22

1 reference

12 November 2017

page(s)

4059-4063

1 reference

Hepatitis C therapeutics: current status and emerging strategies

12 November 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2003.08.050

Recent developments in the discovery of hepatitis C virus serine protease inhibitors--towards a new class of antiviral agents?

27 March 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2003.08.050

Inhibitors of hepatitis C virus NS3.4A protease: an overdue line of therapy.

27 March 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2003.08.050

Highly potent and selective peptide-based inhibitors of the hepatitis C virus serine protease: towards smaller inhibitors.

27 March 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2003.08.050

Alpha-ketoamides, alpha-ketoesters and alpha-diketones as HCV NS3 protease inhibitors

27 March 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2003.08.050

Tetrapeptides as potent protease inhibitors of Hepatitis C Virus full-length NS3 (protease-helicase/NTPase).

27 March 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2003.08.050

Capped dipeptide alpha-ketoacid inhibitors of the HCV NS3 protease

27 March 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2003.08.050

Product inhibition of the hepatitis C virus NS3 protease

27 March 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2003.08.050

Potent peptide inhibitors of human hepatitis C virus NS3 protease are obtained by optimizing the cleavage products

27 March 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2003.08.050

Modification of the N-terminus of peptidomimetic protein tyrosine phosphatase 1B (PTP1B) inhibitors: identification of analogues with cellular activity

27 March 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2003.08.050

Protease inhibitors: current status and future prospects

27 March 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2003.08.050

The design and synthesis of potent inhibitors of hepatitis C virus NS3-4A proteinase

27 March 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2003.08.050

Mechanistic role of an NS4A peptide cofactor with the truncated NS3 protease of hepatitis C virus: elucidation of the NS4A stimulatory effect via kinetic analysis and inhibitor mapping

27 March 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2003.08.050

Solid phase synthesis of peptide aldehyde protease inhibitors. Probing the proteolytic sites of hepatitis C virus polyprotein

27 March 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2003.08.050

Studies on the C-terminal of hexapeptide inhibitors of the hepatitis C virus serine protease.

27 March 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2003.08.050

Macrocyclic inhibitors of the NS3 protease as potential therapeutic agents of hepatitis C virus infection

27 March 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2003.08.050

Solid-phase synthesis of peptidomimetic inhibitors for the hepatitis C virus NS3 protease

27 March 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2003.08.050

A designed P1 cysteine mimetic for covalent and non-covalent inhibitors of HCV NS3 protease.

27 March 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2003.08.050

27 March 2024

Identifiers

1 reference

release_rostzx5vkjcdpc4bxvk2bhywli

12 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rostzx5vkjcdpc4bxvk2bhywli

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference